You are here
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
SBC: CHROMOLOGIC LLC Topic: DHA18006
In order to meet DHA’s need for in-line, non-invasive and non-destructive cell monitoring in dynamically growing cultures, In Phase I, ChromoLogic (CL) developed a prototype system for cell monitoring by optical coherence tomography (CM-OCT). Following thSBIR Phase II 2019 Department of DefenseDefense Health Agency
SBC: MICROAETH CORPORATION Topic: 18NCER2A
As forest fires are increasing in prevalence and intensity there is a need for miniaturized, lower cost, and easily portable air sensors that provide information to first responders, public health managers and communities so informed, timely decisions can be made. PM2.5 is an accepted standard for particulate matter (PM) measurements, but PM2.5 mass measurements cannot identify sources without ana ...SBIR Phase I 2019 Environmental Protection Agency
SBC: CRITICAL INNOVATIONS LLC Topic: DHA191007
The Defense Health Agency seeks to develop a universal, automated needle decompression device to more effectively manage tension pneumothorax on the battlefield. Critical Innovations and KARA & Associates, with consultants Captain David Tanen MD, FAAEM, FSBIR Phase I 2019 Department of DefenseDefense Health Agency
SBC: SA PHOTONICS, LLC Topic: CBD171002
SA Photonics is please to submit the proposal for the HawkEye compact LWIR hyperspectral imaging system. HawkEye leverages SA Photonics previous visible, SWIR, and LWIR programs to result in a compact, hand held, battery operated hyperspectral imager in a low cost design approach. Furthermore, HawkEye will leverages SA Photonics expertise in warfighter body worn equipment and ground troop personal ...SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense
SBC: SA PHOTONICS, LLC Topic: DHA172005
In a multiple patient situation, the medics need all the help they can get. Monitoring several patients is a difficult task, and associating the vital signs data with the right patient is crucial. Providing medics with a tool to assist in this task can grSBIR Phase II 2019 Department of DefenseDefense Health Agency
SBC: AUGMNTR, INC. Topic: DHA191001
The purpose of the MEDIC (Medic’s Enhanced Diagnostic Imaging Companion) system is to provide combat medics, via Augmented Reality (AR), a digitally-superimposed avatar representing the internal anatomy of their Warfighter patient. Phase I of this SBIR pSBIR Phase I 2019 Department of DefenseDefense Health Agency
SBC: LIGHTUP, INC. Topic: 91990019R0011
The team will develop a new component of the AR app, a prototype with computer vision and recognition software to present real-world phenomena that are ordinarily not observable in nature. In Phase I, the research team will create a magnetism module would show students the invisible magnetic field all around them and how it interacts with magnetic objects. At the end of Phase I, in a pilot study w ...SBIR Phase I 2019 Department of EducationInstitute of Education Sciences
SBC: INNOSENSE CORPORATION Topic: CBD181004
Chemical warfare agents such as the lethal nerve agent soman are a major source of risk to military personnel. Currently, pyridostigmine bromide (PB) is the only FDA-approved pretreatment to counteract the effects of soman. The rationale behind PB administration is that it acts as a “temporary” inhibitor of AChE. This precludes nerve agents from irreversible inactivation of AChE, thereby mitig ...SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
SBC: INNOSENSE CORPORATION Topic: DHA19A001
Defense Health Agency (DHA) is seeking a multi-functional diagnostic to determine blood coagulopathy in real time at point-of-care (POC). Blood coagulopathy, resulting in uncontrolled bleeding, is implicated in 80% of operating room deaths and 50% of trauSTTR Phase I 2019 Department of DefenseDefense Health Agency
SBC: NEXTGEN AERONAUTICS, INC. Topic: DHA191010
Accurate, real-time kinematic, kinetic, and biomechanical data on warfighters performing complex tasks, collected for extended periods of time, have enormous potential benefits – they can be used to optimize warfighter physical performance, develop strateSBIR Phase I 2019 Department of DefenseDefense Health Agency